Tech Company Financing Transactions

Spyryx Biosciences Funding Round

5AM Ventures, Canaan Partners and Hatteras Venture Partners participated in a $18 million Series A funding round for Spyryx Biosciences. This venture round was recorded on 5/8/2015.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10 Capitola Dr. 801
Durham, NC 27713
USA

Phone

(919) 899-9399

Website

www.spyryxbio.com

Email Address

[email protected]

Overview

Spyryx Biosciences is developing next generation therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and COPD. We are dedicated to making a difference in the lives of patients and their families who bravely face these diseases every day.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Timothy Shannon

        

VP - Operations

Timm Crowder

        

Browse more venture capital transactions:

Prev: 5/8/2015: Sapho venture capital transaction
Next: 5/8/2015: Musistic venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary